Πέμπτη 5 Ιανουαρίου 2017

Clinical activity, minimal toxicities for HER2-targeted dendritic cell vaccines in early breast cancer patients

Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognise cancer cells and target them for destruction. Researchers from Moffitt Cancer Center report...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iTabVK
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις